GOLDMAN SACHS GROUP INC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$208,000
+118.9%
35,567
-51.2%
0.00%
Q4 2018$95,000
-57.0%
72,909
+13.7%
0.00%
Q3 2018$221,000
-7.9%
64,144
+21.5%
0.00%
Q2 2018$240,000
+287.1%
52,776
+181.9%
0.00%
Q1 2018$62,000
-11.4%
18,722
+4.7%
0.00%
Q4 2017$70,000
-75.9%
17,882
-40.1%
0.00%
Q2 2017$291,000
+148.7%
29,878
+94.3%
0.00%
Q3 2016$117,000
-69.1%
15,378
-50.4%
0.00%
Q3 2015$379,000
-65.3%
31,027
-41.3%
0.00%
Q2 2015$1,092,000
+290.0%
52,870
+299.2%
0.00%
Q1 2015$280,000
-75.2%
13,244
-63.9%
0.00%
Q4 2014$1,128,000
+122.5%
36,652
+27.7%
0.00%
Q3 2014$507,00028,6980.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2015
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders